Research Leadership
Sylvester is led by a dedicated senior leadership team including Interim Director Joseph Rosenblatt, M.D., Deputy Director Marc Lippman, M.D., Chief Medical Officer
W. Jarrard Goodwin, M.D.
and seven associate directors.
Mark Pegram, M.D.
Interim Associate Director, Clinical Research; Interim Division Chief, Hematology/Oncology

Joyce Slingerland, MD, PhD
Interim Associate Director, Translational Research; Director, Braman Family Breast Cancer Institute

Jennifer Hu, Ph.D.
Associate Director, Cancer Prevention and Control

Alan Pollack, MD, PhD
Associate Director, Community Professional Relations

Antonieta Sauerteig, Ph.C.
Associate Director, Administration

Sean Scully, M.D.
Associate Director, Education and Training

Glen Barber, Ph.D.,
Associate Director, Basic Science

Research activities at the cancer center are organized into
seven multidisciplinary research programs —
Biobehavioral Oncology;
Breast
Cancer;
Cancer
Epidemiology & Prevention;
Genitourinary Malignancies;
Molecular Therapeutics;
Tumor Immunobiology; and
Viral Oncology —
that are led by program leaders, whose names are listed below.
Michael Antoni, PhD
Biobehavioral Oncology

Floyd Daniel Armstrong, PhD
Biobehavioral Oncology

Mark Pegram, M.D.
Breast Cancer

Joyce Slingerland, MD, PhD
Breast Cancer

Jennifer Hu, Ph.D.
Cancer Epidemiology and Prevention

Richard Cote, M.D.
Genitourinary Malignancies

Alan Pollack, MD, PhD
Genitourinary Malignancies

Julio Barredo, M.D.
Molecular Therapeutics

Antonio J. Capobianco, Ph.D.
Molecular Therapeutics

Eli Gilboa, Ph.D.
Tumor Immunobiology

Diana Lopez, Ph.D.
Tumor Immunobiology

Glen Barber, Ph.D.,
Viral Oncology

|